Page results
-
This page is for cancer patients receiving immunotherapy treatment.
-
The North Central London Integrated Care System (NCL ICS) has new services and staff training to support patients with inherited red cell disorders, including Sickle Cell and Thalassaemia, living in Barnet, Camden, Enfield, Haringey and Islington.
-
UCLH is delighted to announce the appointment of Dr Steve Harris as Chief Research Information Officer (CRIO).
-
Patients with COVID-19 will be given the cystic fibrosis drug ‘Dornase alfa’ to determine if it can help improve survival by reducing excess inflammation in the lungs in a trial at UCLH.
-
The North Central London Integrated Care System (NCL ICS) has new services and staff training to support patients with inherited red cell disorders, including Sickle Cell and Thalassaemia, living in Barnet, Camden, Enfield, Haringey and Islington.
-
Neurological complications of COVID-19 can include delirium, brain inflammation, stroke and nerve damage, finds a new UCL and UCLH-led study.
-
UCLH will be part of a major UK research study looking at the long-term health impacts of COVID-19.
-
A new study that aims to improve the quality of MRI scans for prostate cancer screening has identified simple ways to treble the number of scans that are of optimal diagnostic quality.
-
This page offers advice to patients who are feeling sick.
-
Participants reacted quicker and made fewer errors during menstruation, despite believing their performance would be worse, according to new research from UCL and the Institute of Sport, Exercise & Health (ISEH).
File results
-
private maternity brochure updated 2023
-
Patient daily headache diary
-
Patient telephone reminder service opt-out form
-
Living with sickle cell disorder guide for patients
-
-
FOI/2023/0820 - Antenatal classes offered in person and online
-
FOI/2021/0040 - Trust's online clinic/video consultation system
-
FOI/2020/0653 - Contract/ framework/ tender used to buy microcatheters
-
FOI/2023/0825 - Treatments for any disease, Berinert, Cinryze, Orladeyo etc/ hereditary angioedema (HAE)
-